ArticleFrontiers in oncology2023

Postoperative adjuvant immunotherapy for high-risk hepatocellular carcinoma patients.

Wei-Qiao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.